Neurodegenerative Disease Clinical Trials in Changsha
2 recruitingChangsha, China
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
DementiaBrain DiseasesCentral Nervous System Diseases+6 more
Eli Lilly and Company1,500 enrolled141 locationsNCT05508789
Recruiting
Sleep Disordered Breathing and Multimorbidity: The Xiangya SDB Cohort Study
Sleep-disordered breathing (SDB)Sleep ApneaCardiometabolic Diseases+2 more
Xiangya Hospital of Central South University15,000 enrolled1 locationNCT06755840